MULTIPLE SCLEROSIS
PharmaLegacy has the expertise and models you need to advance your multiple sclerosis program.
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR HUNTINGTON’S DISEASE PROGRAM.
MODELS / SERVICES
The PharmaLegacy advantage:
- We initiate most studies in under 2 weeks
- Capacity for 200+ concurrent studies
- Scientific staff with 15+ years of experience on average
- 1500+ validated animal models of disease spanning 100+ indications
See why 18 of the top 20 pharmaceutical companies trust PharmaLegacy. Contact us today.
We’re ready when you are.
Tell us your multiple sclerosis pipeline challenges.
